
Marrone Bio Innovations, Inc. (MBII) Stock Overview
Explore Marrone Bio Innovations, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Marrone Bio Innovations, Inc. (MBII)
Key Financials
Key Financials
Market Cap
0
P/E Ratio
-8.43
EPS (TTM)
$-0.12
ROE
-0.54%
MBII Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Marrone Bio Innovations, Inc. (NASDAQ: MBII) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Marrone Bio Innovations, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MBII on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Marrone Bio Innovations, Inc.'s NASDAQ-traded stock include a P/E ratio of -8.43 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of MBII on the NASDAQ.